HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A nonglucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage.

Abstract
Prior studies have demonstrated that intensive treatment with high doses of methylprednisolone (MP) can beneficially affect the acutely injured central nervous system by a variety of mechanisms and promote neurological recovery in experimentally injured animals. In view of the fact that these actions are associated only with MP doses greatly in excess of those required for classical glucocorticoid receptor-mediated actions of the steroid, the possibility was examined that this high-dose pharmacology of MP could be duplicated by a nonglucocorticoid analog. Accordingly, U-72099E (17,21-dihydroxy-11 alpha-t-butylacetoxy-1,4-pregnadiene-3,20-dione- 21-hemisuccinate, sodium salt) was synthesized and tested for its ability to duplicate the high-dose effects of MP in a concussive head injury model in mice and in an in vitro model of lipid peroxidation-induced membrane damage using rat brain synaptosomes. The absence of glucocorticoid-related activity of U-72099E was confirmed by its inability to either suppress body weight gain or cause thymic involution in mice treated with doses up to 100 mg/kg/day for 4 days. On the other hand, MP at 30 mg/kg/day for 4 days caused a complete inhibition of body weight gain and a 43.5% reduction in thymus weight. Moreover, U-72099E, at concentrations of 10(-5) M or lower, failed to suppress adrenocorticotropin secretion by mouse AtT-20 pituitary cells in culture, whereas dexamethasone or MP at concentrations of 10(-6) M and lower caused a marked suppression in adrenocorticotropin secretion.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsE D Hall, J M McCall, R L Chase, P A Yonkers, J M Braughler
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 242 Issue 1 Pg. 137-42 (Jul 1987) ISSN: 0022-3565 [Print] United States
PMID3039107 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Lipid Peroxides
  • U 72099E
  • gamma-Aminobutyric Acid
  • Adrenocorticotropic Hormone
  • Prednisone
  • Methylprednisolone
Topics
  • Adrenocorticotropic Hormone (metabolism)
  • Animals
  • Body Weight (drug effects)
  • Brain (metabolism)
  • Brain Injuries (drug therapy)
  • Cells, Cultured
  • Lipid Peroxides (metabolism)
  • Male
  • Methylprednisolone (analogs & derivatives, pharmacology, therapeutic use)
  • Mice
  • Organ Size (drug effects)
  • Pituitary Gland (drug effects, metabolism)
  • Prednisone (analogs & derivatives, pharmacology, therapeutic use)
  • Synaptic Membranes (metabolism)
  • Synaptosomes (metabolism)
  • Thymus Gland (anatomy & histology, drug effects)
  • gamma-Aminobutyric Acid (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: